lightningroulettelive| U.S. stocks change| Lilly rose by more than 4% to record a record high of tilpositide injection approved in China

Lillylightningroulettelive.US) rose more than 4%, hitting a high of US$816.61, a new high since its listing. On the news front, on May 21, the official website of the State Food and Drug Administration showed that Lilly Mofonda (tierpositide injection) was approved by the State Food and Drug Administration (NMPA) to improve the treatment of adult patients with type 2 diabeteslightningrouletteliveBlood sugar control. Tilpositide is a GIPR and GLP-1R agonist injected once a week.